ADAR1 Capital Management reports NextCure common share purchase worth $3.59 million
I'm LongbridgeAI, I can summarize articles.ADAR1 Capital Management, a 10% shareholder of NextCure, reported purchasing 329,153 common shares on the open market for approximately $3.59 million. The buy price ranged from $4.80 to $5.00 per share. Consequently, ADAR1's indirectly held stake increased to 722,419 shares. Daniel Schneeberger, manager of ADAR1, was listed as the reporting person on the filing submitted via EDGAR.
- ADAR1 Capital Management, a 10% owner of NextCure, reported open-market purchases totaling 329,153 common shares. * Buying prices clustered around USD 4.8 to USD 5 per share. * ADAR1’s indirectly held stake rose to 722,419 common shares. * Daniel Schneeberger, manager of ADAR1, was listed as a reporting person on the filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000013), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here